Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics

Recent studies have reported an increased risk of second primary malignancies (SPM) following multiple myeloma (MM) diagnosis associated with novel anti-myeloma treatments. We evaluated the risk of SPM among 36 491 MM cases reported to the Surveillance, Epidemiology, and End Results program (SEER) b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Razavi, P, Rand, K A, Cozen, W, Chanan-Khan, A, Usmani, S, Ailawadhi, S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3698537/
https://ncbi.nlm.nih.gov/pubmed/23811785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2013.19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados